F

Fenway Health | The Fenway Institute

Research site
(Unclaimed)
Location
1340 Boylston Street, Boston, Massachusetts, United States of America
Site insights

Top conditions

HIV Infections (6 trials)

Infections (5 trials)

Herpes Genitalis (5 trials)

Herpes Simplex (5 trials)

Acquired Immunodeficiency Syndrome (4 trials)

Top treatments

Emtricitabine
Atazanavir
Truvada
Ritonavir
imiquimod
fluorouracil
PrEP
Lenacapavir
Tenofovir

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 33
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults (IPCAVD-012)

The primary purpose of this study is to assess safety/tolerability of the different vaccine regimens and of a late boost vaccination; and to assess e...

Active, not recruiting
Healthy
Other: Placebo
Biological: Clade C gp140 plus adjuvant

The purpose of this study is to generate safety and immunogenicity data and establish a proof-of-concept of clinical benefit of the mRNA-1608 vaccine...

Active, not recruiting
Genital Herpes
Biological: mRNA-1608
Biological: BEXSERO

This is a single-arm, observational study of HIV-negative MSM with substance use disorder. Those who meet pre-screening criteria will attend a Screen...

Enrolling
Substance Use
Adherence, Treatment
Drug: Descovy or Truvada
Device: Beiwe

The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.

Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: Oral Lenacapavir (LEN)
Drug: F/TDF

The randomized phase of the trial compared topical or ablative treatment with active monitoring in preventing anal cancer in patients with human immu...

Active, not recruiting
Anal Cancer
High-grade Squamous Intraepithelial Lesion
Device: laser therapy
Other: clinical observation

Trial sponsors

G

Genocea Biosciences (4 trials)

Mass General Brigham logo

Mass General Brigham (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems